Latest News
Investor Relations
Latest News
November 20, 2024 07:00 am
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
November 12, 2024 07:29 am
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
October 29, 2024 07:00 am
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
October 28, 2024 01:58 pm
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
October 23, 2024 07:00 am
BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT
October 17, 2024 07:00 am
BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment
October 15, 2024 07:00 am
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
October 2, 2024 07:00 am
BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
September 30, 2024 07:00 am